Informativeness of Early Huntington Disease Signs about Gene Status.

about

Linking white matter and deep gray matter alterations in premanifest Huntington disease How tandem gait stumbled into the neurological exam: a review.

P2860

Q36787332-EB39F685-7557-4376-A650-D15FDAABDFA5 Q45304149-F4DF9BD1-D14D-4EEC-8972-4A41E5360A81

P2860

Informativeness of Early Huntington Disease Signs about Gene Status.

Item

http://www.wikidata.org/entity/Q40458680

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Informativeness of Early Huntington Disease Signs about Gene Status.

@en

type

Item

label

Informativeness of Early Huntington Disease Signs about Gene Status.

@en

prefLabel

Informativeness of Early Huntington Disease Signs about Gene Status.

@en

P1476

Informativeness of Early Huntington Disease Signs about Gene Status.

@en

P2093

David Oakes

http://www.w3.org/2001/XMLSchema#string

E Ray Dorsey

http://www.w3.org/2001/XMLSchema#string

Elise Kayson-Rubin

http://www.w3.org/2001/XMLSchema#string

Emily Oster

http://www.w3.org/2001/XMLSchema#string

Ira Shoulson

http://www.w3.org/2001/XMLSchema#string

Shirley W Eberly

http://www.w3.org/2001/XMLSchema#string

P2860

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.

Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study

Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.

Motor abnormalities in premanifest persons with Huntington's disease: the PREDICT-HD study.

Detection of Huntington's disease decades before diagnosis: the Predict-HD study

Cognitive decline in prodromal Huntington Disease: implications for clinical trials.

PRECREST: a phase II prevention and biomarker trial of creatine in at-risk Huntington disease.

Predictors of diagnosis in Huntington disease.

Age at onset and life table risks in genetic counselling for Huntington's disease

P304

271-277

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/JHD-150156

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26444024

http://www.w3.org/2001/XMLSchema#string

P921

Huntington disease

Informativeness of Early Huntington Disease Signs about Gene Status.

about

P2860

P2860

Informativeness of Early Huntington Disease Signs about Gene Status.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921